Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by deepoil0808on Sep 29, 2021 10:26am
137 Views
Post# 33936422

RE:RE:EXPLOSIVE Growth Revenue +600% overwhelms MEDV

RE:RE:EXPLOSIVE Growth Revenue +600% overwhelms MEDVFundamentals always win out.    The share price will make a monumental recovery once the November 2021 financials are in which confirm blockbuster revenue and earnings. 

I cannot speak for the past posts which you mention.

From my end I am only reporting ACTUAL FACTS that have been reported.

Fact #1:

We have an actual press release from MEDV in August 2021 with exact number of tests being done that were tripled from June 2021 and tripled in price.

Fact #2:

We have MEDV clients and mind you they are disgruntled clients who confirm that they had to wait 3 hours in a line up in order to get tested.    We have 20 direct confirmations from clients.     This confirms that MEDV is overwhelmed with tests.

Fact #3

The Department of Health California has confirmed that MEDV is charging fees for 3 tests and, that people are forced to take 3 tests at a price of $ 150.    So we have confirmation that average price is indeed $ 150 per patient way up from $ 58 per patient and, that MEDV forcing only 3 tests shows that they are in command of testings with overwhelming tests.

Fact #4

Lawyer of MEDV responds directly to Department of Health California that testing has EXPLODED 300% since mid August 2021 and that systems of MEDV are overwhelmed.

Fact #5

Knowscarp has cut his beach outings by 75% and is busy posting here as the hedge funds he works for whom have NAKED SHORT SHARES in MEDV are in panic and, forsee huge losses if they need cover at $1.50 per share. 


<< Previous
Bullboard Posts
Next >>